Hyperperfusion Syndrome Following Tissue Plasminogen Activator Administration: A Case Report with Radiological Evidence. [PDF]
Koh NH, Kim SS, Oh HY, Kim S, Jang JW.
europepmc +1 more source
Mechanisms behind elevated serum levels of plasminogen activator inhibitor-1 in frontotemporal lobar degeneration. [PDF]
Angelucci F, Hort J.
europepmc +1 more source
Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis. [PDF]
Khalil M+5 more
europepmc +1 more source
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis. [PDF]
Dang C+6 more
europepmc +1 more source
The dynamic role of soluble urokinase plasminogen activator receptor (suPAR) in monitoring coagulation dysfunction during COVID-19 progression: a review. [PDF]
Obeagu EI.
europepmc +1 more source
Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degeneration. [PDF]
Angelucci F+4 more
europepmc +1 more source
Related searches:
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
The Lancet, 1987A. Hamsten+7 more
semanticscholar +1 more source
Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin
Seminars in Thrombosis and Hemostasis, 2013P. Declerck, A. Gils
semanticscholar +1 more source
Functions of the plasminogen receptor Plg‐RKT
Journal of Thrombosis and Haemostasis, 2020Juliana P Vago+2 more
exaly